Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus.
Oxf Med Case Reports. 2018 Oct;2018(10):omy062
Authors: Al-Obaidi M, Younes P, Ostrosky-Zeichner L
Invasive mucormycosis is typically seen in patients with hematological malignancies, diabetes and other conditions that affect the immune system. However, locally invasive disease can also be seen in both immunocompromised and immunocompetent hosts after trauma and direct inoculation. Since historically post-exposure prophylaxis with lipid-based amphotericin B compounds has not been feasible because of a high toxicity profile, there is no experience regarding the role of post-exposure prophylaxis after injuries contaminated with agents of mucormycosis. We describe the first case of a patient with occupational exposure to Rhizopus that received post-exposure prophylaxis with oral isavuconazole.
PMID: 30250744 [PubMed]